The invention relates to pyrazolo-pyridine compounds which inhibit mitogen-activated protein kinase kinase 4 (MKK4) and in particular, selectively inhibit MKK4 over protein kinases JNK1 and MKK7. The compounds are useful for promoting liver regeneration or reducing or preventing hepatocyte death. They are further useful for treating osteoarthritis or rheumatoid arthritis, or CNS-related diseases.
该发明涉及抑制丝裂原活化蛋白激酶激酶4(MKK4)的
吡唑吡啶化合物,特别是选择性地抑制MKK4而不抑制蛋白激酶JNK1和MKK7。这些化合物可用于促进肝再生或减少或预防肝
细胞死亡。它们还可用于治疗骨关节炎或类风湿关节炎,或中枢神经系统相关疾病。